PHA ACE2 regulation of ACE2
(Die Seite wurde neu angelegt: „{{up|Target ACE2, Spike protein}} {{tp|p=32291076|t=ä. EZH2-mediated H3K27me3 inhibits ACE2 expression |pdf=|usr=}} {{tp|p=32133153|t=2020. Comparative geneti…“) |
|||
Zeile 6: | Zeile 6: | ||
{{ttp|p=32333398|t=2020. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance |pdf=|usr=}} | {{ttp|p=32333398|t=2020. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance |pdf=|usr=}} | ||
{{tp|p=32442315|t=2020. Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs.|pdf=|usr=007}} | {{tp|p=32442315|t=2020. Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs.|pdf=|usr=007}} | ||
+ | {{tp|p=32558150|t=2020. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.|pdf=|usr=010}} | ||
+ | {{tp|p=32891636|t=2020. MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes.|pdf=|usr=019}} | ||
+ | {{tp|p=32940950|t=2020. Effects of Exercise on ACE2.|pdf=|usr=019}} | ||
+ | {{tp|p=33123616|t=2020. The role of nicotinic receptors in SARS-CoV-2 receptor ACE2 expression in intestinal epithelia.|pdf=|usr=020}} | ||
+ | {{tp|p=33292872|t=2020. The role of nicotinic receptors in SARS-CoV-2 receptor ACE2 expression in intestinal epithelia.|pdf=|usr=022}} | ||
+ | {{tp|p=33224734|t=2021. Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2.|pdf=|usr=021}} |
Aktuelle Version vom 27. April 2021, 18:27 Uhr
Target ACE2, Spike protein |
32291076 ä. EZH2-mediated H3K27me3 inhibits ACE2 expression
32133153 2020. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
32372801 2020. (ACE2) Does a cell protein explain covid-19 severity?
32302706 2020. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor
32333398 2020. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance |
32442315 2020. Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs.
32558150 2020. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.
32891636 2020. MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes.
32940950 2020. Effects of Exercise on ACE2.
33123616 2020. The role of nicotinic receptors in SARS-CoV-2 receptor ACE2 expression in intestinal epithelia.
33292872 2020. The role of nicotinic receptors in SARS-CoV-2 receptor ACE2 expression in intestinal epithelia.
33224734 2021. Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2.